NP Life Sciences Health Industry Group Inc. Proceeds from Issuance or Sale of Equity
NP Life Sciences Health Industry Group Inc. (ACAT) reported Proceeds from Issuance or Sale of Equity of $364.43 thousand for the 12-month period ending 2019-12-31, per its 10-K filed 2021-04-15.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromIssuanceOrSaleOfEquity · last filed 2021-04-15
- NP Life Sciences Health Industry Group Inc. proceeds from issuance or sale of equity for the quarter ending 2019-06-30 was $260.13K.
- NP Life Sciences Health Industry Group Inc. proceeds from issuance or sale of equity for the quarter ending 2019-03-31 was $104.30K.
- NP Life Sciences Health Industry Group Inc. proceeds from issuance or sale of equity for fiscal 2019 was $364.43K.
| Period end | Proceeds from Issuance or Sale of Equity 0 month | Proceeds from Issuance or Sale of Equity 3 month | Proceeds from Issuance or Sale of Equity 6 month | Proceeds from Issuance or Sale of Equity 12 month |
|---|---|---|---|---|
| 2019-12-31 | $364.43K 10-K · filed 2021-04-15 | |||
| 2019-06-30 | $260.13K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-14 | $364.43K 10-Q · filed 2020-08-14 | ||
| 2019-03-31 | $104.30K 10-Q · filed 2020-05-15 | |||
| 2018-12-31 | $200.00 10-K · filed 2020-03-30 |